The following trials provide information to treat various types of disease of the brain and the central and local nervous systems, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
- collapse A 12-Week Pilot Study to Compare the Safety and Efficacy of Sustained Release Quetiapine Fumarate (Seroquel SR) Versus Placebo for the Treatment of Patients with Alcohol Dependence
- collapse Rapid Dose Escalation of Quetiapine versus Conventional Escalation in the Treatment of Patients with Acute Schizophrenia, a Multicentre, Double-blind, Parallel group, Randomized Study
- collapse A randomised, parallel group, open trial examining the safety, efficacy and tolerability of fast titration, 800mg/day by day 4, of quetiapine fumarate compared to standard titration, 400mg/day by day 4, in the treatment of Bipolar 1 Manic episode - FATIMA.
- collapse TICOS-
- collapse CNS QOL PhIV Legault LQ
- collapse A post-marketing clinical study (Phase IV) of Seroquel - To assess the efficacy and safety of Seroquel in schizophrenic patients wit positive symptoms.
- collapse Duration of maintenance anti-psychotic therapy after first –episode schizophrenia: a double-blind randomized placebo-control relapse prevention study
- collapse A 1-year, international, multicenter, randomized, double-blind, parallel-group, placebo-controlled phase IV study to evaluate prevention of relapse in patients in stable condition with chronic schizophrenia receiving either quetiapine fumarate IR (SEROQUEL) or placebo.
- collapse A study to characterize the steady-state PK and Safety and tolerability of Seroquel in adults with selected psychotic disorders
- collapse Fast titration of quetiapine in the treatment of schizophrenia/schizoaffective disorder: a one arm phase III open trial
